Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.

Autor: Lucia Suzuki, Fiebo J C Ten Kate, Annieke W Gotink, Hans Stoop, Michail Doukas, Daan Nieboer, Manon C W Spaander, Jan J B van Lanschot, Bas P L van Wijnhoven, Arjun D Koch, Marco J Bruno, Leendert H J Looijenga, Katharina Biermann

Publikováno v: PLoS ONE, Vol 14, Iss 7, p e0219494 (2019)

To date no informative biomarkers exist to accurately predict presence of lymph node metastases (LNM) in esophageal adenocarcinoma (EAC). We studied the discriminative value of Olfactomedin 4 (OLFM4), an intestinal stem cell marker, in EAC. Patients

Externí odkaz: https://doaj.org/article/b4c452dc87ab4dae9827957a23a56e19

Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma

Autor: Katharina Biermann, Bas L.A.M. Weusten, Wouter B. Nagengast, Fiebo J. C. ten Kate, Richard van Hillegersberg, Pieter J F de Jonge, H. Valk, Jaap van der Laan, Wouter L. Curvers, Steffi E. M. van de Ven, Freek Moll, Cees A. Seldenrijk, Lucia Suzuki, Roos E. Pouw, Mark I. van Berge Henegouwen, Thjon J. Tang, Ineke van Lijnschoten, Michael Doukas, Arjun D. Koch, Sybren L. Meijer, A. Alkhalaf, John T. M. Plukker, Lodewijk A.A. Brosens, Bas P. L. Wijnhoven, Daan Nieboer, Lorenza Alvarez Herrero, Jacques J. Bergman, Marco J. Bruno, Gursah Kats-Ugurlu, Annieke W. Gotink, Martin H. Houben

Publikováno v: United European Gastroenterology Journal, 9, 1066-1073
van de Ven, S E M, Suzuki, L, Gotink, A W, ten Kate, F J C, Nieboer, D, Weusten, B L A M, Brosens, L A A, van Hillegersberg, R, Alvarez Herrero, L, Seldenrijk, C A, Alkhalaf, A, Moll, F C P, Curvers, W, van Lijnschoten, I G, Tang, T J, van der Valk, H, Nagengast, W B, Kats-Ugurlu, G, Plukker, J T M, Houben, M H M G, van der Laan, J S, Pouw, R E, Bergman, J J G H M, Meijer, S L, van Berge Henegouwen, M I, Wijnhoven, B P L, de Jonge, P J F, Doukas, M, Bruno, M J, Biermann, K & Koch, A D 2021, ' Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma ', United European Gastroenterology Journal, vol. 9, no. 9, pp. 1066-1073 . https://doi.org/10.1002/ueg2.12151
United European gastroenterology journal, 9(9), 1066-1073. SAGE Publications Inc.
United European Gastroenterology Journal, 9, 9, pp. 1066-1073
United European Gastroenterology Journal, 9(9), 1066-1073. SAGE Publications Inc.
United European Gastroenterology Journal
United European Gastroenterology Journal, 9(9), 1066-1073. SAGE Publishing

Contains fulltext : 245204.pdf (Publisher’s version ) (Open Access) AIM: To quantify lymphovascular invasion (LVI) and to assess the prognostic value in patients with pT1b esophageal adenocarcinoma. METHODS: In this nationwide, retrospective cohort

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e92b8fae71068e112ef344c011330a5b
http://hdl.handle.net/2066/245204

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma

Autor: Fiebo J. C. ten Kate, Michail Doukas, Arjun D. Koch, Leendert H. J. Looijenga, J. Jan B. van Lanschot, Bas P. L. Wijnhoven, Annieke W. Gotink, Lucia Suzuki, Marco J. Bruno, Katharina Biermann, Manon C.W. Spaander, Daan Nieboer, Hans Stoop

Publikováno v: PLoS ONE, Vol 14, Iss 7, p e0219494 (2019)
PLoS One (print), 14(7):e0219494. Public Library of Science
PLoS ONE

To date no informative biomarkers exist to accurately predict presence of lymph node metastases (LNM) in esophageal adenocarcinoma (EAC). We studied the discriminative value of Olfactomedin 4 (OLFM4), an intestinal stem cell marker, in EAC. Patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::419124953eff0574ec1cf6e61aea02d7
https://pure.eur.nl/en/publications/c07edfea-d60e-42c3-8c8c-4820036bfa51